ClinicalTrials.gov
ClinicalTrials.gov Menu

INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 (INCLUDE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03131505
Recruitment Status : Completed
First Posted : April 27, 2017
Last Update Posted : March 29, 2018
Sponsor:
Collaborator:
University of East Anglia
Information provided by (Responsible Party):
Norfolk and Suffolk NHS Foundation Trust

Brief Summary:

The focus of this study is not about what it is like to have a mental disorder, but instead the diagnostic experience.

Some people find diagnoses helpful, but some find them upsetting and harmful. Research is therefore needed to improve diagnostic processes. It has been suggested that patient experiences and outcomes may be affected by the diagnostic tools used, including diagnostic criteria, labels and language. In the NHS, the tool used by doctors to help diagnose people is a guidebook called the International Classification of Diseases (ICD). A new version of this guide is due to be released in 2018.

This project will use focus groups to ask people who use mental health services and diagnosing doctors in those services what they think about the labels and language in the new guide. The investigators can then suggest changes before the guide is published. The investigators hope that this research will improve mental health diagnosis. The research will take place in Norfolk and Suffolk and span eight months.


Condition or disease
Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) Schizophrenia Generalised Anxiety Disorder Bipolar Disorder

Detailed Description:

This is a qualitative project requested by the World Health Organisation (WHO), and planned by Norfolk and Suffolk NHS Foundation Trust and the University of East Anglia. The research aims and design have been developed in consultation with service users, clinicians, academics and the World Health Organisation (WHO). These groups have told the investigators that mental health diagnosis can have unintended, negative consequences. This is supported by a large body of existing research. It has been suggested that patient experiences and outcomes may be affected by the diagnostic classifications used (i.e. labels and language). The investigators plan to explore service users' and clinicians' views on the proposed ICD-11 diagnostic classifications. To do this, the investigators will provide participants with the proposed ICD-11 diagnostic classification relevant to their experience, and conduct focus groups to explore people's views of the new diagnostic classifications, including judgement about the clinical accuracy, the language used, what people think is helpful and unhelpful, and what could be improved. The topic guide for the focus groups will be developed in consultation with the advisory group (comprising service users, carers and clinicians).

The investigators will conduct separate focus groups for service users and clinicians as the investigators believe joint groups may impact the findings. The investigators will collate findings to produce recommendations for the criteria and language proposed for ICD-11. These recommendations will be discussed in feedback groups of service users, carers and clinicians, which will provide further participants an opportunity for additional thoughts and reflection.

Inclusion

  • Adult service users will have formally received one of the five diagnoses under investigation: Unipolar Depression,Schizophrenia, Bipolar Disorder, Generalised Anxiety Disorder or Personality Disorder.
  • Individuals will be excluded if their participation is deemed unsafe to themselves or others by their clinical team or clinicians on the research team.
  • Clinicians will have had experience working with mental health, either as a GP or psychiatrist, where diagnosing one of the above five diagnoses is part of their role.
  • Carers will have had experience looking after someone diagnosed with one of the five diagnoses mentioned above.
  • Participants who have been involved in one aspect of the study will be excluded from taking part in any other aspects (e.g. participants in the focus group may not be involved in other focus or feedback groups).
  • Participants with multiple diagnoses will only be allowed to attend one focus group, but they may choose which one of the relevant focus groups they would like to take part in.

Exclusion:

  • Non-English speakers will not be included in the study.
  • Individuals under 18 years old will be excluded.
  • Individuals who do not have capacity to give consent will be excluded. Individuals who lose capacity at any point between referral and the end of their participation will be removed from the study.

Study Type : Observational
Actual Enrollment : 59 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Perspectives on the INternational CLassification of Diseases (11th Revision); Using Lived Experience to Improve Mental Health Diagnosis in NHS England: INCLUDE Study
Actual Study Start Date : February 22, 2017
Actual Primary Completion Date : December 1, 2017
Actual Study Completion Date : February 21, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mental Health




Primary Outcome Measures :
  1. Qualitative evaluation of the impact of new ICD-11 diagnostic criteria via focus groups with people living with mental health conditions and clinicians. [ Time Frame: 8 months ]
    Focus groups will be undertaken with people who have received a mental health diagnosis (unipolar or bipolar depression, generalised anxiety disorder, schizophrenia, personality disorder) and clinicians working in mental health services. The focus groups will follow a structured topic guide, based around the new diagnostic criteria and language for each condition to understand participants' views on meaning, accessibility, stigma and recovery



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Mental health service users clinicians
Criteria

Inclusion:

  1. Adult service users will have formally received one of the five diagnoses under investigation: Unipolar Depression, Schizophrenia, Bipolar Disorder, Generalised Anxiety Disorder or Personality Disorder.
  2. Clinicians will have had experience working with mental health, either as a GP or psychiatrist, where diagnosing any of the above diagnoses is part of their role.
  3. Carers will have had experience looking after someone with the above diagnoses.
  4. Service users with multiple diagnoses will be allowed to participate, and choose which one of the relevant focus groups they would like to attend.
  5. Service users will be under the care of an NSFT service.

Exclusion:

  1. Individuals under 18 years old.
  2. Individuals who do not have capacity to give consent.
  3. Individuals who lose capacity during the study.
  4. Individuals who do not speak English.
  5. Individuals will be excluded if their participation is deemed unsafe to themselves or others by their lead clinician or clinicians on the research team.
  6. Individuals who have taken part in another group or part of the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03131505


Locations
United Kingdom
Norfolk and Suffolk NHS Foundation Trust
Norwich, United Kingdom, NR6 5BE
Sponsors and Collaborators
Norfolk and Suffolk NHS Foundation Trust
University of East Anglia
Investigators
Principal Investigator: Corinna Hackmann Norfolk and Suffolk NHS Foundation Trust

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Norfolk and Suffolk NHS Foundation Trust
ClinicalTrials.gov Identifier: NCT03131505     History of Changes
Other Study ID Numbers: 216352
First Posted: April 27, 2017    Key Record Dates
Last Update Posted: March 29, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Disease
Schizophrenia
Bipolar Disorder
Anxiety Disorders
Substance-Related Disorders
Personality Disorders
Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders
Bipolar and Related Disorders
Chemically-Induced Disorders